Covered recipient · General Payments record
RACHEL N FORD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Women's Health
General Payments · PY2021–2024
$2,113.31
- Reported across 125 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $646.64 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $399.49 | 22 |
| PFIZER INC. | $60.62 | 3 |
| Inari Medical, Inc. | $34.87 | 2 |
| Acerta Pharma LLC | $34.70 | 2 |
| Amgen Inc. | $30.99 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.56 | 1 |
| Exact Sciences Corporation | $16.40 | 1 |
| Abbott Laboratories | $15.28 | 1 |
| GlaxoSmithKline, LLC. | $15.19 | 1 |
| Lilly USA, LLC | $13.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $15.28 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125002344 | CMS |
| ABBVIE INC. | $20.25 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107118928 | CMS |
| ABBVIE INC. | $6.40 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107118930 | CMS |
| ABBVIE INC. | $7.04 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107118932 | CMS |
| ABBVIE INC. | $19.75 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107118934 | CMS |
| ABBVIE INC. | $22.22 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107118936 | CMS |
| ABBVIE INC. | $23.82 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107118938 | CMS |
| ABBVIE INC. | $15.80 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107118940 | CMS |
| ABBVIE INC. | $20.53 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107118942 | CMS |
| ABBVIE INC. | $17.37 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107118944 | CMS |
| ABBVIE INC. | $25.62 | 06/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107118946 | CMS |
| ABBVIE INC. | $23.92 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107118948 | CMS |
| ABBVIE INC. | $23.62 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107118950 | CMS |
| ABBVIE INC. | $16.03 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107118952 | CMS |
| ABBVIE INC. | $17.37 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107118954 | CMS |
| ABBVIE INC. | $18.88 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107118956 | CMS |
| ABBVIE INC. | $18.12 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107118958 | CMS |
| ABBVIE INC. | $23.41 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107118960 | CMS |
| ABBVIE INC. | $12.05 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107118962 | CMS |
| ABBVIE INC. | $13.38 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107118964 | CMS |
| ABBVIE INC. | $14.96 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107118966 | CMS |
| ABBVIE INC. | $21.16 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107118968 | CMS |
| ABBVIE INC. | $17.79 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107118970 | CMS |
| Amgen Inc. | $17.12 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117555221 | CMS |
| Amgen Inc. | $13.87 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117555219 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.95 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104501834 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.75 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105842217 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.56 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117974103 | CMS |
| Exact Sciences Corporation | $16.40 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114535071 | CMS |
| GlaxoSmithKline, LLC. | $15.19 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116620007 | CMS |
| Inari Medical, Inc. | $20.41 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140182990 | CMS |
| Inari Medical, Inc. | $14.46 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140182992 | CMS |
| Lilly USA, LLC | $13.54 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135899648 | CMS |
| PFIZER INC. | $18.02 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131051892 | CMS |
| PFIZER INC. | $20.37 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131262446 | CMS |
| PFIZER INC. | $22.23 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131965699 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.